Latest market price
59.57
-0.33-0.55%
OverviewShort InterestFilings
ARWRQT33Arrowhead Pharmaceuticals, Inc.·NASDAQ
59.57-0.55%

Latest SEC Filings

Form category
DescriptionFilingDocument
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20263Initial statement of beneficial ownership
Jun 16, 20268-KCurrent report
May 14, 20264Statement of changes in beneficial ownership
May 07, 2026S-8Registration of employee benefit securities
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 06, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 20264Statement of changes in beneficial ownership
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 20268-KCurrent report
Mar 09, 20264Statement of changes in beneficial ownership
Feb 05, 202610-QQuarterly report
Feb 05, 20268-KCurrent report
#1 / 25 of 291
Page
▼
/ 12